Singapore markets close in 1 hour 29 minutes
Straits Times Index
3,213.61 -1.79 (-0.06%) Nikkei
32,315.05 -363.57 (-1.11%) Hang Seng
17,409.71 -319.58 (-1.80%) FTSE 100
7,596.06 -27.93 (-0.37%) Bitcoin USD
26,277.46 +139.95 (+0.54%) CMC Crypto 200
562.16 +2.65 (+0.47%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 363.99M |
| Enterprise value | -171.54M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 7.46 |
| Price/book (mrq) | 0.49 |
| Enterprise value/revenue | -3.54 |
| Enterprise value/EBITDA | 0.90 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.38 |
| 52-week change 3 | -79.23% |
| S&P500 52-week change 3 | 18.92% |
| 52-week high 3 | 8.2450 |
| 52-week low 3 | 1.3900 |
| 50-day moving average 3 | 2.3215 |
| 200-day moving average 3 | 2.6839 |
Share statistics
| Avg vol (3-month) 3 | 709.44k |
| Avg vol (10-day) 3 | 814.54k |
| Shares outstanding 5 | 251.03M |
| Implied shares outstanding 6 | 251.03M |
| Float 8 | 160.33M |
| % held by insiders 1 | 15.72% |
| % held by institutions 1 | 68.50% |
| Shares short (30 Aug 2023) 4 | 22.07M |
| Short ratio (30 Aug 2023) 4 | 35.82 |
| Short % of float (30 Aug 2023) 4 | 12.58% |
| Short % of shares outstanding (30 Aug 2023) 4 | 8.79% |
| Shares short (prior month 30 Jul 2023) 4 | 23.5M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -431.58% |
Management effectiveness
| Return on assets (ttm) | -14.08% |
| Return on equity (ttm) | -26.11% |
Income statement
| Revenue (ttm) | 48.48M |
| Revenue per share (ttm) | 0.19 |
| Quarterly revenue growth (yoy) | -99.90% |
| Gross profit (ttm) | 84.68M |
| EBITDA | -189.48M |
| Net income avi to common (ttm) | -209.5M |
| Diluted EPS (ttm) | -0.8400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 595.75M |
| Total cash per share (mrq) | 2.37 |
| Total debt (mrq) | 66.07M |
| Total debt/equity (mrq) | 8.97% |
| Current ratio (mrq) | 17.63 |
| Book value per share (mrq) | 2.93 |
Cash flow statement
| Operating cash flow (ttm) | -162.74M |
| Levered free cash flow (ttm) | -74.99M |
© 2023 Yahoo. All rights reserved.
